Solannm lyratum extract affected immune response in normal and leukemia murine animal in vivo

Human and Experimental Toxicology

Volumn 29, Issue 5, 2010, Pages 359-367

  Yang, Jai Sing ^a   Wu, Chia Chun ^a   Kuo, Chao Lin ^a   Yeh, Chin Chung ^b   Chueh, Fu Shin ^c   Hsu, Cheng Kuang ^c   Wang, Chien Kuo ^c   Chang, Ching Yao ^c   Ip, Siu Wan ^a   Hsu, Yuan Man ^a   Kuo, Wei Wen ^a   Chung, Jing Gung ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

Immune response; Leukemia murine animal model; Leukemia WEHI 3 cells; Solannm lyratum extract

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; PLANT EXTRACT; SOLANNM LYRATUM EXTRACT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DIFFERENTIATION ANTIGEN; HERBACEOUS AGENT; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; DRUG DOSE INCREASE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL LEUKEMIA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PERITONEUM MACROPHAGE; PHYSIOLOGY; PHYTOTHERAPY; SOLANUM; SPLEEN; TUMOR CELL LINE;

ANIMALIA; CITRUS MACROPHYLLA; MURINAE; MUS; SOLANACEAE; SOLANUM LYRATUM;

ANIMALS; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION; ANTINEOPLASTIC AGENTS, PHYTOGENIC; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; KILLER CELLS, NATURAL; LEUKEMIA, EXPERIMENTAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; PHYTOTHERAPY; PLANT EXTRACTS; SOLANUM; SPLEEN; T-LYMPHOCYTES;

EID: 77951171602     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110364153     Document Type: Article

References (32)

1. Parkin DM, Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 2005 ; 55: 74-108.
2. Evan G., Littlewood T. A matter of life and cell death. Science 1998 ; 281: 1317-1322.
3. Warner NL, Moore MA, Metcalf D. A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst 1969 ; 43: 963-982.
4. He Q., Na X. The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cells in vitro and in vivo. Leuk Res 2001 ; 25: 455-461.
5. Yang JS, Kok LF, Lin YH, et al. Diallyl disulfide inhibits WEHI-3 leukemia cells in vivo. Anticancer Res 2006 ; 26: 219-225.
6. Su CC, Yang JS, Lin SY, et al. Curcumin inhibits WEHI-3 leukemia cells in BALB/c mice in vivo. In Vivo 2008 ; 22: 63-68.
7. Tsou MF, Peng CT, Shih MC, et al. Benzyl isothiocyanate inhibits murine WEHI-3 leukemia cells in vitro and promotes phagocytosis in BALB/c mice in vivo. Leuk Res 2009 ; 33: 1505-1511.
8. Tan TW, Lin YT, Yang JS, et al. A. cantoniensis inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immunoresponses in vivo. In Vivo 2009 ; 23: 561-566.
9. Lin JP, Yang JS, Lu CC, et al. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk Res 2009 ; 33: 823-828.
10. Yalin W., Yuanjiang P., Cuirong S. Isolation, purification and structural investigation of a water-soluble polysaccharide from Solanum lyratum Thunb. Int J Biol Macromol 2005 ; 36: 241-245.
11. Kang B., Lee E., Hong I., et al. Abolition of anaphylactic shock by Solanum lyratum Thunb. Int J Immunopharmacol 1997 ; 19: 729-734.
12. Sun LX, Fu WW, Ren J., et al. Cytotoxic constituents from Solanum lyratum. Arch Pharm Res 2006 ; 29: 135-139.
13. Ren J., Feng GN, Wang MW, et al. Primary study on the anti-tumor effect of ethanol extracts of Solanum lyratum. Zhongguo Zhong Yao Za Zhi 2006 ; 31: 497-500.
14. Shan CM, Li J. Study of apoptosis in human liver cancers. World J Gastroenterol 2002 ; 8: 247-252.
15. Gu SQ, Liang YY, Fan LR, et al. Co-regulative effects of the cAMP/PKA and DAG/PKC signal pathways on human gastric cancer cells during differentiation induced by traditional Chinese medicines. World J Gastroenterol 1997 ; 3: 50-53.
16. Wei X., Li CG, Nong S., et al. The influence of Solanum lyratum Thunb extract on apoptosis and the expression of fas/fasL genes in Hela cells. Zhong Yao Cai 2006 ; 29: 1203-1206.
17. Hsu SC, Lu JH, Kuo CL, et al. Crude extracts of Solanum lyratum induced cytotoxicity and apoptosis in a human colon adenocarcinoma cell line (colo 205). Anticancer Res 2008 ; 28: 1045-1054.
18. Tsou MF, Peng CT, Shih MC, et al. Benzyl isothiocyanate inhibits murine WEHI-3 leukemia cells in vitro and promotes phagocytosis in BALB/c mice in vivo. Leuk Res 2009 ; 33: 1501-1511.
19. Lu HF, Liu JY, Hsueh SC, et al. (-)-Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo. In Vivo 2007 ; 21: 285-289.
20. Yu FS, Yu CS, Chan JK, et al. The effects of emodin on the expression of cytokines and functions of leukocytes from Sprague-Dawley rats. In Vivo 2006 ; 20: 147-151.
21. Lai WW, Yang JS, Lai KC, et al. Rhein induced apoptosis through the endoplasmic reticulum stress, caspase- and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells. In Vivo 2009 ; 23: 309-316.
22. Dickey C. Review reopens old disagreements. Nature Med 2002 ; 8: 1337.
23. Singh NJ, Schwartz RH Primer: mechanisms of immunologic tolerance. Nat Clin Pract Rheumatol 2006 ; 2: 44-52.
24. Matzinger P. The danger model: a renewed sense of self. Science 2002 ; 296: 301-305.
25. Zitvogel L., Tesniere A., Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006 ; 6: 715-727.
26. Rosenberg SA Progress in human tumour immunology and immunotherapy. Nature 2001 ; 411: 380-384.
27. Unanue ER Antigen-presenting function of the macrophage. Annu Rev Immunol 1984 ; 2: 395-428.
28. Oflazoglu E., Stone IJ, Gordon KA, et al. Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30. Blood 2007 ; 110: 4370-4372.
29. Dunn GP, Bruce AT, Ikeda H., et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002 ; 3: 991-998.
30. Haliotis T., Ball JK, Dexter D., et al. Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice. Int J Cancer 1985 ; 35: 505-513.
31. Gorelik E., Wiltrout RH, Brunda MJ, et al. Augmentation of metastasis formation by thioglycollate-elicited macrophages. Int J Cancer 1982 ; 29: 575-581.
32. Smyth MJ, Thia KY, Street SE, et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000 ; 191: 661-668.